{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:23:10Z","timestamp":1760188990468},"reference-count":34,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T00:00:00Z","timestamp":1209859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>We compared androgen and gonadotropin values in HIV\u2010infected men who did and did not develop lipoatrophy on combination antiretroviral therapy (cART).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From a population of 136 treatment\u2010na\u00efve male Caucasians under successful zidovudine\/lamivudine\u2010based cART, the 10 patients developing lipoatrophy (cases) were compared with 87 randomly chosen controls. Plasma levels of free testosterone (fT), dehydroepiandrosterone (DHEA), follicle\u2010stimulating hormone and luteinizing hormone (LH) were measured at baseline and after 2 years of cART.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At baseline, 60% of the cases and 71% of the controls showed abnormally low fT values. LH levels were normal or low in 67 and 94% of the patients, respectively, indicating a disturbance of the hypothalamic\u2013pituitary\u2013gonadal axis. fT levels did not significantly change after 2 years of cART. Cases showed a significant increase in LH levels, while controls showed a significant increase in DHEA levels. In a multivariate logistic regression model, lipoatrophy was associated with higher baseline DHEA levels (<jats:italic>P<\/jats:italic>=0.04), an increase in LH levels during cART (<jats:italic>P<\/jats:italic>=0.001), a lower body mass index and greater age.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Hypogonadism is present in the majority of HIV\u2010infected patients. The development of cART\u2010related lipoatrophy is associated with an increase in LH and a lack of increase in DHEA levels.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2008.00578.x","type":"journal-article","created":{"date-parts":[[2008,5,5]],"date-time":"2008-05-05T03:07:37Z","timestamp":1209956857000},"page":"427-432","source":"Crossref","is-referenced-by-count":13,"title":["Androgen and gonadotropin patterns differ in HIV\u20101\u2010infected men who develop lipoatrophy during antiretroviral therapy: a case\u2013control study"],"prefix":"10.1111","volume":"9","author":[{"given":"DM","family":"Wunder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CA","family":"Fux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NA","family":"Bersinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NJ","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Hirschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Cavassini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Elzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Swiss HIV Cohort Study","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,8]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90144-1"},{"key":"e_1_2_6_3_2","first-page":"729","article-title":"Endocrine function in 98 HIV\u2010infected patients","volume":"5","author":"Raffi F","year":"1991","journal-title":"a prospective study"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/135965350701200215","article-title":"Hypogonadism in HIV\u20101\u2010infected men is common and does not resolve during antiretroviral therapy","volume":"12","author":"Wunder DM","year":"2007","journal-title":"Antivir Ther"},{"key":"e_1_2_6_5_2","first-page":"726","article-title":"An objective case definition of lipodystrophy in HIV\u2010infected adults","volume":"361","author":"Carr A","year":"2003","journal-title":"a case\u2013control study"},{"key":"e_1_2_6_6_2","first-page":"225","article-title":"Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV\u2010infected patients on highly active antiretroviral therapy (HAART)","volume":"25","author":"Vigouroux C","year":"1999","journal-title":"Diab Metab"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200202010-00002"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06102-4"},{"key":"e_1_2_6_9_2","first-page":"F25","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy","volume":"14","author":"Carr A","year":"2000","journal-title":"contribution to protease inhibitor-related lipodystrophy syndrome"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200301030-00017"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000187443.30838.3e"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350701200407"},{"key":"e_1_2_6_13_2","first-page":"999","article-title":"Toxicogenetics of antiretroviral therapy","volume":"12","author":"Tarr PE","year":"2007","journal-title":"genetic factors that contribute to metabolic complications"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000189852.21441.2a"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(01)00196-5"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000183629.20041.bb"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/322695"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-199208000-00012"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/317457"},{"key":"e_1_2_6_20_2","first-page":"934","article-title":"Sexual hormones in HIV\u2010infected patients","volume":"16","author":"Collazos J","year":"2002","journal-title":"the influence of antiretroviral therapy"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-56-6-1278"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2004.05051.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2001.002002136.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05463.x"},{"key":"e_1_2_6_25_2","first-page":"2243","article-title":"Effect of DHEA on abdominal fat and insulin action in elderly women and men","volume":"292","author":"Villareal DT","year":"2004","journal-title":"a randomized controlled trial"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00784.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2190"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-10-807"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.46.521"},{"key":"e_1_2_6_30_2","first-page":"786","article-title":"Metabolic effects of rosiglitazone in HIV lipodystrophy","volume":"140","author":"Hadigan C","year":"2004","journal-title":"a randomized, controlled trial"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-5-200509060-00009"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.06.014"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-006-5022-y"},{"key":"e_1_2_6_34_2","first-page":"429","article-title":"No effect of rosiglitazone for treatment of HIV\u20101 lipoatrophy","volume":"363","author":"Carr A","year":"2004","journal-title":"randomised, double-blind, placebo-controlled trial"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1086\/518005"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2008.00578.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2008.00578.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:04:12Z","timestamp":1696863852000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2008.00578.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1111\/j.1468-1293.2008.00578.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2008.00578.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"type":"print","value":"1464-2662"},{"type":"electronic","value":"1468-1293"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}